break and come back at 9:23.
DR. KIBBE: If we could start to settle down or settle down to start or whichever way you want to put it.
I have been informed that I cannot start the open hearing sooner to try to fit more time in for our speakers because of the way it is announced in the Federal Register, and so it has to start at exactly 11:30, no sooner, which means that Dr. Adams and his colleagues will have additional time to more completely describe for us dose content uniformity, parametric tolerance interval test for aerosol products, and I think we'll benefit from that, as soon as the electronics are ready.
Dr. Adams, you're on.
DR. ADAMS: Yes. Thank you, Dr. Kibbe.
Dr. Kibbe, advisory members, good morning. I'm pleased to be here and have an opportunity to discuss the dose content uniformity work which we have been involved in for a period of time.
I'd like to note that this topic, at least my presentation, is called dose content uniformity for